Nanotech Briefs has announced a Call for Nominations for its fourth annual Nano 50 awards competition, which launched on January 7. The Nano 50 recognizes the top 50 technologies, innovators, and products with the greatest potential to advance the commercialization of nanotechnology.
T2 Biosystems, Inc., a company developing the first portable medical diagnostic products which combine nanotechnology and miniaturized magnetic resonance (MR) technology, today announced significant research findings that support the advancement and development of nanoparticle-based, magnetic resonance technology that offer rapid, portable diagnostic testing.
Arrowhead Research Corporation announced today the appointment of Dr. Mauro Ferrari to its newly established Board of Scientific Strategy. He is one of the most well-known experts in leveraging nanotechnology to treat and diagnose cancer. Dr. Ferrari will serve as a Director of Scientific Strategy and will be integral in building out the new advisory board and guiding Arrowhead's operations and strategic plan.
AMI Semiconductor (NASDAQ: AMIS), a leading designer and manufacturer of state-of-the-art mixed-signal and digital products for the automotive, medical, industrial, aerospace, and high-voltage communication markets, has entered into a new two-year collaboration program with IMEC - Europe's leading independent research center in the field of nanoelectronics - to develop AMI Semiconductor’s future Smart Power Technologies.
Nanotechnology-enabled energy technologies, printable electronics and nanobiotechnology are just three of the many panel topics to be presented at the IBF's 2008 Nano Applications and Advanced Materials Forum that will take place February 5-6 in Indian Wells, California.
Keller and Heckman LLP and NanoReg are hosting a nanoregulation workshop on March 20, 2008 in Baltimore, Maryland. This conference is immediately following the Global Chemical Regulations Conference at the Marriott Baltimore Waterfront Hotel.
Arrowhead's new President and Chief Executive Officer. On December 3, 2007, Dr. Anzalone was granted an option to purchase 2,000,000 shares of the common stock of Arrowhead at an exercise price of $3.92, the closing price of Arrowhead's shares on that date.
The pharmaceutical industry in India has made phenomenal progress in the past 10 years. With over $ 8 billion in domestic sales and another $ 5 billion in exports in the year 2006, both growing at double digit, it has acquired its place in the sun. It has also started making global footprints and over $ 2.5 billion worth of acquisitions were made overseas in past couple of years.
This evening at its premiere awards event, the KTEC PIPELINE announced Olga Koper, NanoScale Corporation, Manhattan, Kan., as the KTEC PIPELINE 'Innovator of the Year.' The 'Innovator of the Year' was chosen after a competition that included a refined business plan, a pitch to an expert panel and a score carried over from performance during the technology fellowship year.
Product sales for the quarter increased 25% over the prior-year quarter to $4.25 million from $3.40 million. Total revenue, consisting of product sales and contract research and development revenue, increased 23% to $4.77 million for the third quarter of fiscal 2008 from $3.86 million in the prior-year quarter. Net income for the third quarter of fiscal 2008 increased 62% to $1.70 million, or $0.36 per diluted share, compared to $1.05 million, or $0.22 per share, for the prior-year quarter.